Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Aberforth Split Level Income T ASIZ Dec 13, 2019 109.04 0.00   
 Aberforth Split Level Income T ASIT Dec 13, 2019 92.88 +9.91   
 Access Intelligence ACC Dec 13, 2019 50.00 +4.17   
 Accesso Technology Group Plc ACSO Dec 13, 2019 522.00 -1.51   
 Accrol Group Holdings Plc ACRL Dec 13, 2019 31.00 +2.06   
 Accsys Technologies AXS Dec 13, 2019 92.00 -1.67   
 Acer Incorporated ACID Dec 13, 2019 3.12 0.00   
 Acorn Income Fund AIF Dec 13, 2019 382.75 +3.38   
 Acorn Income Fund ZC PRF REDEE AIFZ Dec 13, 2019 154.00 0.00   
 Acron AKRN Dec 13, 2019 7.65 0.00   
 Active Energy Group plc AEG Dec 13, 2019 0.50 +4.17   
 Actual Experience plc ACT Dec 13, 2019 95.00 0.00   
 Adamas Finance Asia Limited ADAM Dec 13, 2019 24.00 0.00   
 Adams Plc ADA Dec 13, 2019 4.10 0.00   
 Adept Technology Group Plc ADT Dec 13, 2019 330.00 +3.14   
 Adept4 Plc AD4 Dec 13, 2019 1.93 0.00   
 ADES International Holding Plc ADES Dec 13, 2019 11.00 -2.65   
 ADM Energy Plc ADME Dec 13, 2019 4.55 0.00   
 Admiral Group PLC ADM Dec 13, 2019 2 202.00 +2.80   
 Advanced Medical Solutions Gro AMS Dec 13, 2019 267.00 -0.19   
 Advanced Oncotherapy Plc AVO Dec 13, 2019 37.50 -0.73   
 Advfn plc AFN Dec 13, 2019 20.48 -8.41   
 Aeorema Communications Group P AEO Dec 13, 2019 38.00 0.00   
 AEW UK Long Lease REIT Plc AEWL Dec 13, 2019 70.32 +0.46   
 AEW UK REIT Plc AEWU Dec 13, 2019 96.29 +2.66   
 AFC Energy Plc AFC Dec 13, 2019 14.45 -3.67   
 Afh Financial Group Plc AFHP Dec 13, 2019 325.00 +4.84   
 AFI Development AFRB Dec 13, 2019 0.29 0.00   
 AFI DEVELOPMENT PLC AFID Dec 13, 2019 0.29 -0.68   
 Africa Opportunity Fund Ltd AOF Dec 13, 2019 0.55 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now